
CTA-Based Mapping of Pulmonary Artery Pseudoaneurysms: A New Standard for Hemoptysis Management
Radiologists and pulmonologists increasingly rely on Computed Tomography Angiography (CTA) to manage pulmonary artery pseudoaneurysms. These vascular lesions often cause life-threatening hemoptysis, particularly in clinical settings where tuberculosis is prevalent. Historically, clinicians considered Digital Subtraction Angiography (DSA) the gold standard. However, advanced CTA now provides precise vascular mapping that significantly streamlines the intervention process.
Vascular Classification of Pulmonary Artery Pseudoaneurysms
Current research categorizes these lesions into four distinct types based on their blood supply. Type A involves a pure pulmonary artery supply. Type B features a dual supply from both stenosed pulmonary and systemic artery branches. In Type C cases, the supply originates entirely from bronchial or non-bronchial systemic arteries. Finally, Type D represents cases visible on CTA but not immediately apparent on DSA.
Effective Management of Pulmonary Artery Pseudoaneurysms
This imaging-based classification directly informs the selection of endovascular treatments. For example, clinicians typically treat Type A lesions with pulmonary artery embolization (PAE). Conversely, Type C cases often require bronchial artery embolization (BAE). Type B usually necessitates a combined approach to address both vascular sources. Furthermore, CTA guidance reduces unnecessary vessel cannulation and limits contrast exposure during procedures. Consequently, this targeted strategy enhances both technical and clinical success rates in managing moderate to massive hemoptysis.
Evidence shows that CTA has excellent concordance with DSA for Type A and B lesions. While Type C shows moderate agreement, the initial CTA remains a vital roadmap. Ultimately, utilizing CTA-based mapping ensures a more efficient and safer intervention for patients with complex pulmonary vascular pathology.
Frequently Asked Questions
How does CTA improve the management of PAPs?
CTA provides a pre-procedural roadmap that identifies the specific vascular supply of the pseudoaneurysm. This allows interventionalists to target the correct vessel immediately, reducing procedure time and contrast use.
What are the four types of pulmonary artery pseudoaneurysms?
PAPs are classified as Type A (pulmonary supply), Type B (dual pulmonary and systemic supply), Type C (systemic supply), and Type D (detected only on CTA).
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Kumaraswamy C et al. Pulmonary Artery Pseudoaneurysms: Evaluation of Computed Tomography Angiography-based Vascular Mapping and Classification. J Thorac Imaging. 2026 Feb 23. doi: 10.1097/RTI.0000000000000875. PMID: 41725059.
2. Gorsi U et al. Percutaneous transthoracic embolisation for massive haemoptysis secondary to peripheral pulmonary artery pseudoaneurysms. Eur Radiol. 2021;31(4):2134-2141.
3. Khalil A et al. Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest. 2008;133(1):212-219.

More from MedShots Daily

A new study evaluates CTA-based mapping for pulmonary artery pseudoaneurysms (PAPs), showing how specific classifications guide successful embolization....
2 months ago

A global survey reveals that despite high treatment compliance, many haemophilia patients still suffer from joint issues and frequent bleeding episodes....
Today

A new study reveals that disclosing Breast Cancer Polygenic Risk Scores significantly reduces decisional conflict for women with BRCA1/2 variants....
Today

Procizumab is a humanized antibody that neutralizes circulating DPP3, a biological driver of shock, by preventing angiotensin II degradation....
Today

Medtronic has announced its plans to acquire SPR Therapeutics for $650 million, expanding its non-opioid, minimally invasive chronic pain treatments....
Today

Research highlights sex-specific roles of oxytocin neurons in the hypothalamus and signaling in the nucleus accumbens regarding juvenile social play behavio...
Today